1-4 of 4
Marta Canelo-Vilaseca
Close
Sort by
Journal Articles

Beyond MIPI: Harnessing Machine Learning and Histological Subtype for Enhanced MCL Prognostication of Survival

Adrian Mosquera Orgueira, Alba Carbita, Victor Navarro Garces, Pau Abrisqueta, Rodrigo Alonso Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 4419.
https://doi.org/10.1182/blood-2023-179174
Published: 2023
Journal Articles

Impact of the Current Treatments on the Survival of Patients with Mantle Cell Lymphoma (MCL): A Real-Life Study on Behalf of the Spanish Group of Lymphoma (GELTAMO)

Ana Marin Niebla, Mariana Bastos-Oreiro, Alba Cabirta Touzón, Marta Canelo Vilaseca, Juan-Manuel Sancho, Ana Jimenez Ubieto, Adolfo Jesús Sáez Marín, Ana Garcia Noblejas, Pablo Prieto Martinez, Concepcion Nicolas, Carlos Grande Garcia, Hugo Daniel Luzardo Henriquez, Jose Angel Hernandez Rivas, Ana Muntanola, Rosalia Alonso Trillo, Irene Arnaiz, Eva Donato, Paola Villafuerte Gutierrez, Daniel Garcia Belmonte, Alicia Roldan Perez, Sandra Suarez Ordonez, Víctor Navarro Garces, Francesc Bosch, Pau Abrisqueta
Journal: Blood
Blood (2023) 142 (Supplement 1): 1678.
https://doi.org/10.1182/blood-2023-186101
Published: 2023
Journal Articles

A Novel Machine-Learning Model to Predict Early Relapse in Mantle Cell Lymphoma (MCL)

Alba Cabirta Touzón, Adrian Mosquera Orgueira, Victor Navarro Garces, Pau Abrisqueta, Rodrigo A Salcedo Pereda, Carlos Aliste Santos, Marta Canelo Vilaseca, Marina Gomez Rosa, Alberto Lopez Garcia, Tomas Garcia, Fatima De la Cruz Vicente, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Gloria Iacoboni, Moraima Jiménez, Cecilia Carpio, Cristina Garcia, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin Niebla
Journal: Blood
Blood (2023) 142 (Supplement 1): 1675.
https://doi.org/10.1182/blood-2023-181628
Published: 2023
Journal Articles

Rituximab Maintenance (RM) after First-Line (1L) Treatment Is Associated with a Lower Risk of Early-POD in Patients with Mantle Cell Lymphoma (MCL)

Alba Cabirta, Pau Abrisqueta, Víctor Navarro Garcés, Marta Canelo-Vilaseca, Marina Gomez-Rosa, Alberto Lopez García, Tomas García, Fatima De la Cruz, Juan-Manuel Sancho, Eduardo Rios Herranz, Raul Cordoba, Angel Serna, Moraima Jiménez, Sabela Bobillo, Marta Julia, Cecilia Carpio, Gloria Iacoboni, Laura Gallur, Josep Castellvi, Francesc Bosch, Ana Marin-Niebla
Journal: Blood
Blood (2022) 140 (Supplement 1): 9335–9337.
https://doi.org/10.1182/blood-2022-163180
Published: 2022